Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

In many cases, we’ve simply layered new tools onto an outdated operating model. The structure beneath—the way clinical trials ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

Raghu Punnamraju, Velocity Clinical Research Chief Technology Officer ...

Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement ...

PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...

A new project by a team of researchers across the nation analyzes the ways in which digitized health data, artificial ...

The way we study new medicines and treatments is changing quickly. One of the biggest reasons for this change is the use of ...

Artificial Intelligence (AI) is no longer just a buzzword it is transforming the way healthcare is delivered and its influence is now reaching deep into the world of clinical trials from predicting ...